Table 1 Number and (%) of manual and analytical evaluation of various parameters
Parameter | Descriptive | Numeric | Rank | Visual read (out of N = 300) | CLINITEK (out of N = 300) |
|---|---|---|---|---|---|
Leukocytes (Leu/µl) | neg/normal | 0 | 0 | 139 (46.3) | 102 (34.0) |
trace | 15 | 1 | 38 (12.7) | 73 (24.3) | |
+ | 70 | 2 | 39 (13.0) | 73 (24.3) | |
++ | 125 | 3 | 68 (22.7) | 25 (8.3) | |
+++ | 500 | 4 | 14 (4.7) | 23 (7.7) | |
nd | 2 (0.7) | 4 (1.3) | |||
Nitritesa,b | neg/normal | na | 0 | 272 (90.7) | 263 (87.7) |
positive | na | 2 | 28 (9.3) | 35 (11.7) | |
nd | 0 (0) | 2 (0.7) | |||
Urobilinogena (E.U./dl; mmol/l) | neg/normal | 0.2,1; 3.2, 16 | 0 | 292 (97.3) | 280 (93.3) |
+ | 2; 33 | 2 | 5 (1.7) | 9 (3.0) | |
++ | 4; 66 | 3 | 2 (0.7) | 6 (2.0) | |
+++ | ≥ 131; 8 | 4 | 1 (0.3) | 2 (0.7) | |
nd | 0 (0) | 3 (1.0) | |||
Proteins (g/l; mg/dl) | neg/normal | 0 | 0 | 154 (51.3) | 96 (32.0) |
trace | 0.2; trace | 1 | 59 (19.7) | 31 (10.3) | |
+ | 0.3; 30 | 2 | 50 (16.7) | 69 (23.0) | |
++ | 1; 100 | 3 | 29 (9.7) | 76 (25.3) | |
+++ | ≥ 3; 300 | 4 | 8 (2.7) | 26 (8.7) | |
nd | 0 (0) | 2 (0.7) | |||
Blood (Eur/µl) | neg/normal | 0 | 0 | 107 (35.7) | 111 (37.0) |
trace | 10 | 1 | 38 (12.7) | 40 (13.3) | |
+ | 25 | 2 | 14 (4.7) | 18 (6.0) | |
++ | 80 | 3 | 45 (15.0) | 51 (17.0) | |
+++ | 200 | 4 | 95 (31.7) | 80 (26.7) | |
nd | 1 (0.3) | 0 (0) | |||
Ketone bodies (mg/dl) | neg/normal | 0 | 0 | 278 (92.7) | 264 (88.0) |
trace | 5 | 1 | 20 (6.7) | 33 (11.0) | |
+ | 15 | 2 | 1 (0.3) | 2 (0.7) | |
++ | 40 | 3 | 0 (0) | 0 (0) | |
+++ | 80 | 4 | 0 (0) | 0 (0) | |
++++ | 160 | 5 | 0 (0) | 0 (0) | |
nd | 1 (0.3) | 0 (0) | |||
Bilirubina | neg/normal | na | 0 | 220 (73.3) | 220 (73.3) |
+ | na | 2 | 51 (17.0) | 74 (24.7) | |
++ | na | 3 | 25 (8.3) | 5 (1.7) | |
+++ | na | 4 | 3 (1.0) | 1 (0.3) | |
nd | 1 (0.3) | 0 (0) | |||
Glucosec (g/dl; mg/dl) | neg | 0 | 0 | 299 (99.7) | 297 (99.0) |
+ | 0.25; 250 | 2 | 0 (0) | 3 (1.0) | |
nd | 1 (0.3) | 0 (0) |